Author:
Lanzillo R.,Sparaco M.,Lavorgna L.,Carmisciano L.,Signoriello E.,Signori A.,Costabile T.,Maniscalco G. T.,Saccà F.,Cepparulo S.,Russo C. V.,Bisecco A.,Frattaruolo N.,Strianese A.,Lus G.,Brescia Morra V.,Bonavita S.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine
Reference22 articles.
1. Laroni A, Signori A, Maniscalco GT, Lanzillo R, Russo CV, Binello E, Lo Fermo S, Repice A, Annovazzi P, Bonavita S, Clerico M, Baroncini D, Prosperini L, la Gioia S, Rossi S, Cocco E, Frau J, Torri Clerici V, Signoriello E, Sartori A, Zarbo IR, Rasia S, Cordioli C, Cerqua R, di Sapio A, Lavorgna L, Pontecorvo S, Barrilà C, Saccà F, Frigeni B, Esposito S, Ippolito D, Gallo F, Sormani MP, iMUST group. (2017) Assessing association of comorbidities with treatment choice and persistence in MS: a real-life multicenter study. Neurology 89: 2222–2229
2. D’Amico E, Leone C, Caserta C et al (2015) Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal. Expert Rev Neurother 15:803–824
3. Lanzillo R, Prosperini L, Gasperini C, Moccia M, Fantozzi R, Tortorella C, Nociti V, Annovazzi P, Cavalla P, Radaelli M, Malucchi S, Clerici VT, Boffa L, Buttari F, Ragonese P, Maniscalco GT, di Filippo M, Buscarinu MC, Pinardi F, Gallo A, Coghe G, Pesci I, Laroni A, Gajofatto A, Calabrese M, Tomassini V, Cocco E, Solaro C, R.I.Re.MS study group. (2018) R.I.Re.MS study group. A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study. J Neurol 265(5):1174–1183
4. Havrdova E, Galetta S, Stefoski D et al (2010) Freedom from disease activity in multiple sclerosis. Neurology 74(Suppl. 3):S3–S7
5. US Department of Health and Human Services Food and Drug Administration, FDA (2009). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献